Tuesday, July 8, 2008
FDA Approves New Genetic Test for Patients with Breast Cancer
The U.S. Food and Drug Administration has approved a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab).
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment